Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gleevec
Pharma
FDA approves Shorla's oral liquid version of Novartis' Gleevec
Shorla has scored an FDA nod for its strawberry-flavored drink version of Novartis' Gleevec.
Kevin Dunleavy
Nov 26, 2024 11:18am
Aerovate's stock plummets after sole product fails in PAH trial
Jun 17, 2024 7:25pm
ASCO: Novartis' Scemblix proves benefits over Gleevec in CML
May 31, 2024 8:00am
Takeda's Iclusig tops Novartis' Gleevec decisively in Ph+ALL
Feb 14, 2023 5:00pm
In Ph+ALL trial, Takeda's Iclusig outdoes Novartis' Gleevec
Nov 17, 2022 10:27am
ASCO: Novartis eyes full nod for Gleevec follow-on Scemblix
May 26, 2022 5:00pm
